1. Home
  2. BHM vs ANL Comparison

BHM vs ANL Comparison

Compare BHM & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

N/A

Current Price

$8.58

Market Cap

51.9M

Sector

Real Estate

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$1.48

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHM
ANL
Founded
2022
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
52.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
BHM
ANL
Price
$8.58
$1.48
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$15.00
N/A
AVG Volume (30 Days)
4.6K
28.5K
Earning Date
01-01-0001
04-20-2026
Dividend Yield
5.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$74,462,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
27.95
N/A
52 Week Low
$8.05
$0.88
52 Week High
$14.81
$2.99

Technical Indicators

Market Signals
Indicator
BHM
ANL
Relative Strength Index (RSI) 38.75 55.10
Support Level $8.05 $0.88
Resistance Level $8.88 $1.59
Average True Range (ATR) 0.39 0.17
MACD -0.04 0.02
Stochastic Oscillator 33.16 83.89

Price Performance

Historical Comparison
BHM
ANL

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: